Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian cancer—a retrospective cohort study

BACKGROUND: The systemic immune-inflammation index (SII) has been proven to be related to the prognoses of multiple malignant tumors. However, there are still few studies on the relationship between the SII and the effect of neoadjuvant chemotherapy in patients with ovarian cancer. It is of great si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Yin, Shuping, Chen, Kewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638786/
https://www.ncbi.nlm.nih.gov/pubmed/36353589
http://dx.doi.org/10.21037/gs-22-459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638786/
https://www.ncbi.nlm.nih.gov/pubmed/36353589
http://dx.doi.org/10.21037/gs-22-459

Ejemplares similares